ArticleFrontiers in oncology2020

KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic Cholangiocarcinoma.

Bo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.